Fig. 3: Changes in serum CRP levels after nivolumab administration among three CRP kinetics subgroups in oesophageal cancer. | BJC Reports

Fig. 3: Changes in serum CRP levels after nivolumab administration among three CRP kinetics subgroups in oesophageal cancer.

From: C-reactive protein kinetics as a predictive marker for long-term outcome of immune checkpoint inhibitors in oesophagogastric cancer

Fig. 3

The graph shows the mean ± standard deviation for each group (a). Distribution of treatment responses according to RECIST among the three CRP kinetics subgroups in oesophageal cancer (b). P values were calculated using Fisher’s exact test for the disease control rate. CRP C-reactive protein, DCR disease control rate, CR complete response, PR partial response, SD stable disease, PD progressive disease.

Back to article page